NVIDIA BioNeMo Enables Generative AI for Drug Discovery on AWS
NVIDIA News, Tuesday, November 28,2023
Pharma and techbio companies can access the NVIDIA Clara healthcare suite, including BioNeMo, now via Amazon SageMaker and AWS ParallelCluster - and coming to NVIDIA DGX Cloud on AWS.
Researchers and developers at leading pharmaceutical and techbio companies can now easily deploy NVIDIA Clara software and services for accelerated healthcare through Amazon Web Services.
Announced today at AWS re:Invent, the initiative gives healthcare and life sciences developers using AWS cloud resources the flexibility to integrate NVIDIA-accelerated offerings such as NVIDIA BioNeMo - a generative AI platform for drug discovery - coming to NVIDIA DGX Cloud on AWS, and currently available via the AWS ParallelCluster cluster management tool for high performance computing and the Amazon SageMaker machine learning service.